Calcium antagonists for aneurysmal subarachnoid haemorrhage

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Dorhout Mees, S M ^b   Rinkel, Gabriel J E ^a   Feigin, V L ^b   Algra, A ^b   Van Den Bergh, W M ^b   Vermeulen, M ^b   Van Gijn, J ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

Calcium channel blockers *therapeutic use ; Humans; Intracranial aneurysm *complications ; Nimodipine therapeutic use ; Randomized controlled trials as topic; Subarachnoid hemorrhage *drug therapy; etiology ; Treatment outcome

Indexed keywords

CALCIUM ANTAGONIST; FASUDIL; MAGNESIUM SULFATE; NICARDIPINE; NIMODIPINE; PLACEBO;

BILIARY TRACT DISEASE; BLEEDING; BRADYCARDIA; BRAIN ARTERY ANEURYSM; BRAIN HEMATOMA; CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG INDICATION; FATALITY; HEART ATRIUM FIBRILLATION; HUMAN; HYPERMAGNESEMIA; HYPOTENSION; INJECTION SITE PAIN; INJECTION SITE PHLEBITIS; ISCHEMIA; KIDNEY FAILURE; LIVER DYSFUNCTION; LUNG EDEMA; META ANALYSIS; NEUROPROTECTION; PHLEBITIS; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; SUBARACHNOID HEMORRHAGE; SURVIVAL; SYSTEMATIC REVIEW; UREMIA; VASOSPASM;

EID: 41749085693     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD000277.pub3     Document Type: Review

References (67)

1. Allen 1983 {published data only} Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Chou SN, et al.Cerebral arterial spasm - a controlled trial of nimodipine in patients with subarachnoid hemorrhage. New England Journal of Medicine 1983;308:619-24.
2. Ferro 1990 {unpublished data only} Ferro JM, Melo TP, Oliveira V, Trindade AM, Lobo-Antunes J, Campos JC. Prevention of vasospasm in subarachnoid hemorrhage with oral nicardipine. Unpublished study (personal communication) 1990.
3. Haley 1993 {published data only} Haley EC, Kassell NF, Torner JC. A randomised controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 1993;78:537-47.
4. Haley EC, Kassell NF, Torner JC. A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. Journal of Neurosurgery 1993;78:548-53.
5. Haley EC, Kassell NF, Torner JC, Kongable G. Nicardipine ameliorates angiographic vasospasm following subarachnoid hemorrhage. Neurology 1991;41(Suppl 1):346.
6. Han 1993 {published and unpublished data} Han DH, Lee SH, Lee SH. Effect of nimodipine treatment on outcome in surgical cases of aneurysmal SAH. Journal of Neurosurgery 1993;78:346A.
7. Luo 1996 {published data only} Luo W, Qiu S, MA W. Clinical study of magnesium sulphate on delayed cerebral vasospasm after subarachnoid haemorrhage. Journal of Clinical Neurology 1996;9(4):244-5.
8. Messeter 1987 {published data only} Messeter K, Brandt L, Ljunggren B, Svendgaard NA, Algotsson L, Romner B, et al.Prediction and prevention of delayed ischemic dysfunction after aneurysmal subarachnoid hemorrhage and early operation. Neurosurgery 1987;20:548-53.
9. Neil-Dwyer 1987 {published data only} Mee E, Dorrance D, Lowe D, Neil-Dwyer G. Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery 1988;22:484-91.
10. Mee EW, Dorrance DE, Low D, Neil-Dwyer G. Cerebral blood flow and neurological outcome: a controlled study of nimodipine in patients with subarachnoid haemorrhage. Journal of Neurology and Psychiatry 1986;49:469.
11. Neil-Dwyer G, Mee E, Dorrance D, Lowe D. Early intervention with nimodipine in subarachnoid haemorrhage. European Heart Journal 1987;8:41-7.
12. Ohman 1991 {published data only} Juvela S, Kaste M, Hillbom M. Effect of nimodipine on platelet function in patients with subarachnoid hemorrhage. Stroke 1990;21:1283-8.
13. Ohman J. Surgery for ruptured intracranial aneurysms: defining the present optimal conditions. Finland: Helsingin Yliopisto, 1991.
14. Ohman J, Heiskanen O. Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. Journal of Neurosurgery 1988;69(5):683-6.
15. Ohman J, Servo A, Heiskanen O. Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgery. Journal of Neurosurgery 1991;74:8-13.
16. Petruk 1988 {published data only} Disney LB. Cerebral vasospasm following subarachnoid hemorrhage: clinical investigation of oral nimodipine and factors influencing outcome (hemorrhage). Dissertation Abstracts International 1990; Vol. Volume 52/11-B:221 pages.
17. Petruk KC, West M, Mohr G, Weir BKA, Benoit BG, Gentili F, et al.Nimodipine treatment in poor-grade aneurysm patients. Results of a multicentre double-blind placebo-controlled trial. Journal of Neurosurgery 1988;68:505-17.
18. Philippon 1986 {published data only} Philippon J, Grob R, Dagreou F, Guggiari M, Rivierez M, Viars P. Prevention of vasospasmin subarachnoid haemorrhage. A controlled study with nimodipine. Acta Neurochirurgica 1986;82:110-4.
19. Pickard 1989 {published data only} Pickard JD, Murray GD, Illingworth R, Shaw MDM, Teasdale GM, Foy PM, et al.Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 1989;298:636-42.
20. Shibuya 1992 {published data only} Shibuya M, Suzuki Y. Treatment of cerebral vasospasm by a protein kinase inhibitor AT877 [Japanese]. No to Shinkei - Brain & Nerve 1993;45:819-24.
21. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, et al.Effect of AT877 on cerebral vasospasmafter aneurysmal subarachnoid hemorrhage. Results of a prospective placebo controlled double blind trial. Journal of Neurosurgery 1992;76:571-7.
22. van den Bergh 2005 {published data only} van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, et al.Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 2005;36:1011-5.
23. Veyna 2002 {published data only} Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, et al.Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery 2002;96:510-4.
24. Wong 2006 {published data only} Boet R, Chan MTV, Poon WS, Wong GKC, Wong HT, Gin T. Intravenous magnesium sulfate to improve outcome after aneurysmal subarchnoid hemorrhage: interim report from a pilot study. Acta Neurochirurgica 2005;95(Suppl):263-4.
25. Wong GKC, Chan MTV, Boet R, Poon WS, Gin T. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study. Journal of Neurosurgery and Anesthesiology 2006;18(2):142-8.
26. Zhu 2001 {published data only} Zhu Y. Clinical study of nimodipine in preventing and treating cerebral vasospasm after subarachnoid hemorrhage. Chinese Journal of Primary Medicine and Pharmacy 2001;8:256-7.
27. Cabral 1991 *Cabral ND, Scaff M. Use of nimodipine in spontaneous meningeal haemorrhage through aneurysm rupture [Uso da nimodipina em hemorragia meníngea espontânea por rotura de aneurisma]. Revista Brasileira de Neurologia 1991;27(1):21-2.
28. Cadoux-Hudson 1999 Cadoux-Hudson TAD. A randomised, double-blind placebo controlled pilot trial of intravenous magnesium sulphate in subarachnoid haemorrhage. National Research Register, Issue 1 2001.
29. Islekel 1999 Islekel S, Oktar N, Yurtseven T, Ozdamar N. Effect of nimodipine on the outcome of patients after aneurysm surgery. Journal of Neurological Sciences 1999;16(1):4.
30. Jan 1988 Desbordes JM, Ades PE, Guggiari M. Intravenous nimodipine in curative treatment of cerebral vasospasm after subarachnoid haemorrhage caused by rupture of intra-cranial aneurysms: a comparative multicenter study. Agressologie 1989;30:438-40.
31. Frerebeau Ph, Janny P, Taquoi G, Besson G, Buchheit F, Childs M, et al.Curative intravenous nimodipine treatment of subarachnoidal hemorrhage of vasospasm origine intracranial-aneurysms. Neurochirurgie 1988;34:383-8.
32. Jan M, Buchheit F, Tremoulet M. Therapeutic trial of intravenous nimodipine in patients with established cerebral vasospasmafter rupture of intracranial aneurysms. Neurosurgery 1988;23:154-7.
33. Maldonado 1990 Maldonado JA, Milchorena G, Lopez-Camacho O, Madrazo I. Management with nimodipine of the cerebral vasospasm secondary to subarachnoid hemorrhage due to the rupture of an intracranial aneurysm [Manejo con nimodipina del vaso-espasmo cerebral secundario a hemorragia subaracnoidea por ruptura de aneuisma intracraneano]. Archivos de Investigacion Medica 1990;21:179-87.
34. Prevedello 2006 Prevedello DMS, Cordeiro JG, de Morais AL, Saucedo NS, Chen IB, Araujo JC. Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity. Surgical Neurology 2006;65(S1):14-21.
35. Wang 1995 Wang H, Song D, Lu J, Jia S. Preventive effect of nimodipine on SAH and CVS. Journal of Apoplexy and Nervous Diseases 1995;12(4):237.
36. Xie 1994 Xie R, Yao J. Observation on the therapeutic effect of nimodipine versus kang-xuan-ding versus placebo for 14 days. Journal of Clinical Neurology 1994;7(1):48-9.
37. Zhu 1996 Zhu S, Liu X, Li Y, Hou Q, Cai P. Observation of therapeutic effect of combined nimodipine and magnesium sulphate after subarachnoid haemorrhage. Stroke and Nervous Diseases 1996;3(3):163.
38. IMASH Intravenous Magnesium sulfate in Aneurysmal Subarachnoid Hemorrhage. http://www.surgery.cuhk.edu.hk/imash-trial/.
39. MASH-II Major ongoing trials. Stroke 2006; Vol. 37, issue 10:e36-44.
40. ACROSS 2000 The ACROSS Group. Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke 2000;31(8):1843-50.
41. Barker 1996 Barker II FG, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. Journal of Neurosurgery 1996;84:405-14.
42. Brilstra 2000 Brilstra EH, Rinkel GJE, Algra A, van Gijn J. Rebleeding, secondary ischemia and timing of operation in patients with subarachnoid hemorrhage. Neurology 2000;55:1656-60.
43. de Rooij 2006 de Rooij NK, Linn FHH, van der Plas JAP, Algra A, Rinkel GJE. Incidence of subarachnoid hemorrhage: a ten years' update of a systematic review with emphasis on role of region, gender, age and time trend. In preparation.
44. Deeks 2001 Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: EggerM, Davey SmithG, AltmanDG editor(s). Systematic reviews in health care: meta-analysis in context. 2nd Edition. London: BMJ, 2001.
45. Gaab 1985 Gaab MR, Haubitz I, Brawanski A, Korn A, Czech T. Acute effects of nimodipine on the cerebral blood flow and intracranial pressure. Neurochirurgia 1985;28(Suppl 1):93-9.
46. Haley 1994 Haley EC Jr, Kassell NF, Torner JC, Truskowski LL, Germanson TP. A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. Journal of Neurosurgery 1994;80:788-96.
47. Hop 1997 Hop JW, Rinkel GJE, Algra A, van Gijn J. Case fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke 1997;28:660-4.
48. Ljunggren 1984 Ljunggren B, Brandt L, Saveland H, Nilsson PE, Cronqvist S, Andersson KE, et al.Outcome in 60 consecutive patients treated with early aneurysm operation and intravenous nimodipine. Journal of Neurosurgery 1984;61:864-73.
49. Mascio 1994 Mascio RD, Marchioli R, Tognoni G. Meta-analysis. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders. Clinical Trials and Meta-Analysis 1994;29:57-79.
50. Massiou 1992 Massiou H, Chaumet-Riffaud P, Bourdeix I. Nicardipine in the prevention of spasm-induced neurological deficits after subarachnoid hemorrhage: a dose-ranging study. Surgical Neurology 1992;38:7-11.
51. McCalden 1989 McCalden TA, Nath RG. Cerebrovascular autoregulation is resistant to calcium channel blockage with nimodipine. Experientia 1989;45:305-6.
52. Pickard 1990 Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, et al.Oral nimodipine and cerebral ischaemia following subarachnoid haemorrhage. British Journal of Clinical Practice 1990;44(2):66-7.
53. Ram 1991 Ram Z, Sadeh M, Shacked I, Sahar A, Hadani M. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 1991;22(7):922-7.
54. Robinson 1990 Robinson MJ, Teasdale GM. Calcium antagonists in the management of subarachnoid haemorrhage. Cerebrovascular & Brain Metabolism Reviews 1990;2:205-26.
55. Roos 2000 Roos YB, de Haan RJ, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M. Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. Journal of Neurology Neurosurgery and Psychiatry 2000;68(3):337- 41.
56. Satoh 1992 Satoh S, Suzuki Y, Harada T, Ikegaki I, Asano T, Shibuya M, et al.Possible prophylactic potential of HA1077, a Ca+2 channel antagonist and vasodilator, on chronic cerebral vasospasm. European Journal of Pharmacology 1992;220:243-8.
57. Schulz 1995 Schulz K, Chalmers I, Hayes R, Altman D. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408- 12.
58. Seto 1995 Seto M, Shindo K, Ito K, Sasaki Y. Selective inhibition of myosin phosphorylation and tension of hyperplastic arteries by the kinase inhibitor HA1077. European Journal of Pharmacology 1995;276:27-33.
59. Shibuya 1990 Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, et al.Dose escalation trial of a novel calcium antagonist, AT877, in patients with aneurysmal subarachnoid haemorrhage. Acta Neurochirurgica 1990;107:11-5.
60. Takizawa 1993 Takizawa S, Hori M, Ozaki H, Karaki H. Effects of isoquinoline derivatives, HA1077 and H-7, on cytosolic Ca+2 level and contraction in vascular smooth muscle. European Journal of Pharmacology 1993;250:431-7.
61. Tettenborn 1990 Tettenborn D, Dycka J. Prevention and treatment of delayed ischemic dysfunction in patients with aneurysmal subarachnoid hemorrhage. Stroke 1990;21(Suppl IV):IV85-IV89.
62. van den Bergh 2002 van den Bergh WM, Zuur JK, Kamerling NA, van Asseldonk JT, Rinkel GJ, Tulleken CA, et al.Role of magnesium in the reduction of ischemic depolarization and lesion volume after experimental subarachnoid hemorrhage. Journal of Neurosurgery 2002;97(2):416-22.
63. van den Bergh 2003 van den Bergh WM, Algra A, van der Sprenkel JW, Tulleken CA, Rinkel GJ. Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery 2003;52(2):276-82.
64. van den Bergh 2004 van den Bergh WM, Dijkhuizen RM, Rinkel GJ. Potentials of magnesium treatment in subarachnoid haemorrhage. Magnesium Research 2004;17(4):301-13.
65. van der Schaaf 2002 van der Schaaf IC, Ruigrok YM, Rinkel GJE, Algra A, van Gijn J. Study design and outcome measures in studies on aneurysmal subarachnoid hemorrhage. Stroke 2002;33:2043-6.
66. Feigin 1998 Feigin VF, Rinkel GJE, Algra A, Vermeulen M, van Gijn J. Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology 1998;50:876-83.
67. Rinkel 2005 Rinkel GJE, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database of Systematic Reviews 2005, Issue 1.Art. No.: CD000277. DOI:10.1002/14651858.CD000277.pub3.